Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment

Published:2023-10-01 Issue:10 Volume:43 Page:
ISSN:0271-5333
Container-title:RadioGraphics
language:en
Short-container-title:RadioGraphics

Author:

Adrada Beatriz E.¹^ORCID,Moseley Tanya W.¹^ORCID,Kapoor Megha M.¹^ORCID,Scoggins Marion E.¹,Patel Miral M.¹^ORCID,Perez Frances¹^ORCID,Nia Emily S.¹^ORCID,Khazai Laila¹,Arribas Elsa¹^ORCID,Rauch Gaiane M.¹^ORCID,Guirguis Mary S.¹^ORCID

Affiliation:

1. From the Departments of Breast Imaging (B.E.A., T.W.M., M.M.K., M.E.S., M.M.P., F.P., E.S.N., E.A., G.M.R., M.S.G.), Breast Surgical Oncology (T.W.M.), Pathology-Anatomical (L.K.), and Abdominal Imaging (G.M.R.), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030.

Funder

National Institutes of Health

National Cancer Institute

The University of Texas MD Anderson Cancer Center

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rg.230034

Reference68 articles.

1. Molecular Classification of Infiltrating Breast Cancer: Toward Personalized Therapy

2. Epidemiology of Triple-Negative Breast Cancer

3. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

4. Relationship of established risk factors with breast cancer subtypes

5. Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of risk assessment for breast cancer molecular subtypes;Breast Cancer Research and Treatment;2024-06-25

2. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-04

3. Prognostic Molecular Biomarkers in Breast Cancer Lesions with Non-Mass Enhancement on MR;Diagnostics;2024-03-30

4. Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis;International Journal of Genomics;2023-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3